Eris Lifesciences' Swiss Parenterals units faced HALMED observations on GMP compliance.

Eris Lifesciences LimitedERIS · Filed with the exchange

While existing business sees minimal impact, expect delays in their EU-CDMO product pipeline.

Remediation is underway.

No comments yet. Be the first.

More from Eris Lifesciences Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.